OINDP researchers with a particular interest in powder flow and rheology should take note that poster abstract submission and early registration for Powder Flow 2011 end on November 4. The meeting is organized by the Formulation Science and Technology Group of the Royal Society of Chemistry. Many of the members of the organizing committee have connections to the … [Read more...] about Powder Flow 2011 deadlines approaching
Features
News from the 2011 AAPS annual meeting
The 2011 annual meeting of the American Association of Pharmaceutical Scientists in Washington, DC, which took place from October 23-27, included presentations of research related to OINDPs in several formats: a pre-workshop on "Developing Pharmaceutical Products for Controlled Pulmonary Delivery"; a roundtable discussion titled, "QbD in Dry Powder Inhaler … [Read more...] about News from the 2011 AAPS annual meeting
Rise in ICS therapy for US children leads to huge increase in medication expenditures
Over the past few months, the US Health and Human Service Department’s Agency for Healthcare Research and Quality (AHRQ) has issued several statistical briefs and a research finding regarding rising expenditures for asthma medications used to treat children in the US. The researchers from AHRQ examined data from the 1997–2008 Medical Expenditure Panel Survey (MEPS) to … [Read more...] about Rise in ICS therapy for US children leads to huge increase in medication expenditures
FDA reaching out to Primatene Mist inhaler users in advance of phaseout
Armstrong Pharmaceuticals, the manufacturer of the over-the-counter epinephrine MDI Primatene Mist, has been warning consumers to stock up on the product prior to its phaseout at the end of 2011, and now the US FDA is joining the effort to alert users of the inhaler. Primatene Mist is one of the last CFC inhalers marketed in the US to be phased out in conformance with … [Read more...] about FDA reaching out to Primatene Mist inhaler users in advance of phaseout
Proveris Scientific Corp vs. InnovaSystems, Inc has some OINDP developers caught in the middle
On or about September 6, 2011, United States District Court Judge William G. Young will hold a hearing to issue sanctions against InnovaSystems for contempt of court, having ruled that Innova has violated a permanent injunction against sales of its optical spray analyzing system. The hearing will be the latest milestone in a long-running legal dispute between … [Read more...] about Proveris Scientific Corp vs. InnovaSystems, Inc has some OINDP developers caught in the middle
A Q&A with Mark Copley about new nebulizer testing requirements
Mark Copley of Copley Scientific answers questions about upcoming changes to nebulizer testing requirements. Q: What are the new nebulizer testing requirements, and when do they come into force? A: Both the United States Pharmacopoeia (USP) and the European Pharmacopoeia (Ph. Eur.) are introducing new monographs relating to the testing of nebulizers within the … [Read more...] about A Q&A with Mark Copley about new nebulizer testing requirements
UK issues new outcomes strategy for COPD and asthma
Acknowledging that in its treatment of asthma and COPD, "we deliver health outcomes that fall some way behind those achieved by the best-performing countries, or the outcomes public health specialists and clinicians tell us are achievable," the UK's National Health Service (NHS) has issued a new strategy for treatment of those diseases. The document says that it aims … [Read more...] about UK issues new outcomes strategy for COPD and asthma
AANMA sponsors inhaler design contest
The Allergy & Asthma Network Mothers of Asthmatics (AANMA) is currently sponsoring an "Ultimate Inhaler Contest," challenging lay people to "invent the ultimate inhaled medication device." The organization is a 25-year-old US-based non-profit that provides education to and advocates for asthma patients. The contest is open to all ages, with submissions grouped into … [Read more...] about AANMA sponsors inhaler design contest
Imaging/CFD methods could save millions in OINDP development costs
Jan De Backer, CEO of Antwerp-based FluidDA, calculates that the combination of biomedical imaging and computational fluid dynamics offered by his company has the potential to reduce development costs for OINDPs by hundreds of millions of dollars. According to De Backer, FluidDA’s functional imaging methods provide significantly more sensitive parameters for measuring … [Read more...] about Imaging/CFD methods could save millions in OINDP development costs
Next RDD Europe will be in Athens, Greece
At the end of the 2011 RDD Europe conference in Berlin, co-organizers RDD Online and Aptar Pharma announced that the next RDD Europe meeting will take place in Athens, Greece at the Athens Hilton Hotel, May 21-24, 2013. Aptar Pharma’s Pierre Carlotti explains that the organizers are making an effort to choose varied locations for the RDD Europe conference, and … [Read more...] about Next RDD Europe will be in Athens, Greece